Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options.

[1]  D. Tu,et al.  A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer , 2010, Cancer.

[2]  M. McGurk,et al.  Major and minor salivary gland tumors. , 2003, Critical reviews in oncology/hematology.

[3]  T. Negri,et al.  Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). , 2009, Oral oncology.

[4]  S. Cedrés,et al.  Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab‐based therapy , 2008, Head & neck.

[5]  M. Nashed,et al.  Biological therapy of salivary duct carcinoma , 2008, The Journal of Laryngology & Otology.

[6]  R. Weber,et al.  Differential Expression of Hormonal and Growth Factor Receptors in Salivary Duct Carcinomas: Biologic Significance and Potential Role in Therapeutic Stratification of Patients , 2007, The American journal of surgical pathology.

[7]  J. Sercarz,et al.  Salivary duct carcinoma: A clinical and histologic review with implications for trastuzumab therapy , 2007, Head & neck.

[8]  F. Caponigro,et al.  Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. , 2007, Oral oncology.

[9]  L. Licitra,et al.  Systemic therapy in the palliative management of advanced salivary gland cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  T. Löning,et al.  Clinical and immunohistologic typing of salivary duct carcinoma , 2005, Cancer.

[11]  C. Langer,et al.  HER2 Expression in Salivary Gland Carcinomas , 2004, Clinical Cancer Research.

[12]  A. Colevas,et al.  Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study. , 2003, Oral oncology.

[13]  L. Licitra,et al.  A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  T. Moriki,et al.  Salivary duct carcinoma , 2001, Cancer.

[15]  E. Barnes,et al.  Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. , 2000, The American journal of surgical pathology.

[16]  C. Grandi,et al.  Salivary duct carcinoma: Clinical characteristics and treatment strategies , 1997, Head & neck.

[17]  R. Demicheli,et al.  Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  P. Gabriele,et al.  Chemotherapy for recurrent salivary gland malignancies: experience of the ENT Department of Turin University. , 1994, ORL; journal for oto-rhino-laryngology and its related specialties.

[19]  L. Licitra,et al.  Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients , 1991, Cancer.

[20]  J. Eveson,et al.  WHO International Histological Classification of Tumours. Tentative Histological Classification of Salivary Gland Tumours. , 1990, Pathology, research and practice.

[21]  W. Hong,et al.  Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Gabriele,et al.  Cisplatin, Epirubicin and 5-Fluorouracil Combination Chemotherapy for Recurrent Carcinoma of the Salivary Gland , 1989, Tumori.

[23]  D. Schaid,et al.  Cisplatin‐based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck , 1988, Cancer.

[24]  M. Posner,et al.  Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin , 1987, Cancer.

[25]  K. Fu,et al.  Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  O. Kleinsasser,et al.  Duct carcinoma of the salivary glands: Eine den Milchgangcarcinomen der Brustdrse analoge Gruppe von Speicheldrusentumoren , 1968 .

[27]  O. Kleinsasser,et al.  [Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma]. , 1968, Archiv fur klinische und experimentelle Ohren- Nasen- und Kehlkopfheilkunde.